Answers are grounded in this paper and cite their sources.
In this report, we review the clinical, biochemical, pathophysiologic, and therapeutic aspects of cerebrotendinous xanthomatosis. We stress the importance of early diagnosis and treatment. In addition, we describe our experience in treating patients with chenodeoxycholic acid, an essential drug for this disorder that is no longer available.
No takes yet. Share an insight, caveat, or question.
Federico et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: